Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Sebastiani

Showing results (121-130 of 178) with videos related to

Pageof 18
Sort By:
Clinical Rheumatology|April 21, 2021
Retention rate of a second line with a biologic DMARD after failure of a first-line therapy with abatacept, tocilizumab, or rituximab: results from the Italian GISEA registryMarco Sebastiani, Vincenzo Venerito, Serena Bugatti, et al.
Rheumatology International|January 3, 2025
Similar Hepatitis B virus reactivation risk for patients with inflammatory arthritis or connective tissue diseases: a multicenter retrospective studyMaria Pappa, Alexandra Koutsogianni, Anastasios Karamanakos, et al.
Journal of Clinical Medicine|October 27, 2022
Arthritis in Systemic Lupus Erythematosus: From 2022 International GISEA/OEG SymposiumFulvia Ceccarelli, Marcello Govoni, Matteo Piga, et al.
Autoimmunity Reviews|September 20, 2016
International diagnostic guidelines for patients with HCV-related extrahepatic manifestations. A multidisciplinary expert statementClodoveo Ferri, Manuel Ramos-Casals, Anna Linda Zignego, et al.
Reumatismo|November 11, 2024
The holistic management of peripheral spondyloarthritis: focus on articular involvement in patients with inflammatory bowel diseaseEnnio Lubrano, Alessandro Armuzzi, Silvia Scriffignano, et al.
Joint Bone Spine|September 13, 2017
Incidence of cancer in patients with spondyloarthritis treated with anti-TNF drugsFabiola Atzeni, Antonio Carletto, Rosario Foti, et al.
Archives of Rheumatology|August 28, 2020
Factors Predicting Early Failure of Etanercept in Rheumatoid Arthritis: An Analysis From the Gruppo Italiano di Studio sulla Early Arthritis (Italian Group for the Study of Early Arthritis) RegistryMarco Sebastiani, Andreina Manfredi, Florenzo Iannone, et al.
Seminars in Arthritis and Rheumatism|December 24, 2025
Prevalence, incidence and mortality of interstitial lung disease in patients with Sjogren disease: data from the prospective observational "EMERGE" studyAndreina Manfredi, Caterina Vacchi, Stefania Cerri, et al.
Internal and Emergency Medicine|June 12, 2020
Safety and effectiveness of biosimilar of Rituximab CT-P10 in the treatment of cryoglobulinemic vasculitis: the MARBLe study (Mixed cryoglobulinemiA Rituximab BiosimiLar)Caterina Vacchi, Marcella Visentini, Laura Gragnani, et al.
Autoimmunity Reviews|June 11, 2019
Recommendations for managing the manifestations of severe and life-threatening mixed cryoglobulinemia syndromeMassimo Galli, Giuseppe Monti, Piero Marson, et al.
Pageof 18

Showing results (121-130 of 178) with videos related to

Sort By:
Pageof 18
Clinical Rheumatology|April 21, 2021
Retention rate of a second line with a biologic DMARD after failure of a first-line therapy with abatacept, tocilizumab, or rituximab: results from the Italian GISEA registryMarco Sebastiani, Vincenzo Venerito, Serena Bugatti, et al.
Rheumatology International|January 3, 2025
Similar Hepatitis B virus reactivation risk for patients with inflammatory arthritis or connective tissue diseases: a multicenter retrospective studyMaria Pappa, Alexandra Koutsogianni, Anastasios Karamanakos, et al.
Journal of Clinical Medicine|October 27, 2022
Arthritis in Systemic Lupus Erythematosus: From 2022 International GISEA/OEG SymposiumFulvia Ceccarelli, Marcello Govoni, Matteo Piga, et al.
Autoimmunity Reviews|September 20, 2016
International diagnostic guidelines for patients with HCV-related extrahepatic manifestations. A multidisciplinary expert statementClodoveo Ferri, Manuel Ramos-Casals, Anna Linda Zignego, et al.
Reumatismo|November 11, 2024
The holistic management of peripheral spondyloarthritis: focus on articular involvement in patients with inflammatory bowel diseaseEnnio Lubrano, Alessandro Armuzzi, Silvia Scriffignano, et al.
Joint Bone Spine|September 13, 2017
Incidence of cancer in patients with spondyloarthritis treated with anti-TNF drugsFabiola Atzeni, Antonio Carletto, Rosario Foti, et al.
Archives of Rheumatology|August 28, 2020
Factors Predicting Early Failure of Etanercept in Rheumatoid Arthritis: An Analysis From the Gruppo Italiano di Studio sulla Early Arthritis (Italian Group for the Study of Early Arthritis) RegistryMarco Sebastiani, Andreina Manfredi, Florenzo Iannone, et al.
Seminars in Arthritis and Rheumatism|December 24, 2025
Prevalence, incidence and mortality of interstitial lung disease in patients with Sjogren disease: data from the prospective observational "EMERGE" studyAndreina Manfredi, Caterina Vacchi, Stefania Cerri, et al.
Internal and Emergency Medicine|June 12, 2020
Safety and effectiveness of biosimilar of Rituximab CT-P10 in the treatment of cryoglobulinemic vasculitis: the MARBLe study (Mixed cryoglobulinemiA Rituximab BiosimiLar)Caterina Vacchi, Marcella Visentini, Laura Gragnani, et al.
Autoimmunity Reviews|June 11, 2019
Recommendations for managing the manifestations of severe and life-threatening mixed cryoglobulinemia syndromeMassimo Galli, Giuseppe Monti, Piero Marson, et al.
Pageof 18